CEO: Scott L. Tarriff

Sector: Healthcare

Exchange: NASDAQ Global Market

Country: USA

Description: Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology.


Key numbers

Market Capitalization:876412140
Shares Outstanding: 14862000
Float: 13001857
Next Earning Date:2020-02-25
TTm EPS: 1.8338
TTm Dividend Rate:
200 days moving average:56.28
50 days moving average: 58.57
One day percent Change: -0.97



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,